Accumulating research has revealed that tau plays a crucial role in the severity and progression of cognitive impairments (Furman et al., 2017), and that the immunological inhibition of tau has beneficial effects in the therapy of degenerative diseases (Albert et al., 2019; Takeda, 2019; Colin et al., 2020). Here, MAPT is linked to neurodegenerative disease.